Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

NCI begins pediatric study of carboplatin/RMP-7 combination

Aug. 16, 1996

FDA approves new formulation of Gensi Laboratories' etoposide

Aug. 9, 1996

Water-soluble prodrug of pancratistatin synthesized by Arizona State University

Aug. 9, 1996

Mylan to market generic Taxol in 3 countries

Aug. 9, 1996

RPR seeks approval of Campto in 13 European countries

Aug. 9, 1996

Aryl-ureido anticancer agents reported by Universite Laval

Aug. 9, 1996

Ethyol available on Canadian market

July 26, 1996

TPO711: Thrombopoietin useful as bone marrow cell proliferation therapy

July 26, 1996

Anticancer oligonucleotides from Taiho

July 26, 1996

Human Genome Sciences' VIGF antagonists in pipeline

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...